98%
921
2 minutes
20
Background: Placebo and nocebo effects have been thoroughly studied during the last decades using pain models. Two characteristics have been investigated, namely the direction of the effects (i.e., placebo, amelioration of symptoms/nocebo, worsening of symptoms) and their magnitude (i.e., the robustness of the effects). Here, we propose an investigation of the placebo effects considering a third characteristic: time. We employed functional near-infrared spectroscopy (fNIRS), an emerging neuroimaging technique suitable for long-term monitoring and ecological experimental paradigms, to investigate cerebral cortices' activity through oxy-haemoglobin (OHb).
Method: 42 healthy volunteers were randomised into three groups (No Expectations-NE, Placebo 5'-P5 and Placebo 20'-P20), placebo groups received different information on the timing of a cream's effectiveness (i.e., "the cream will work in 5/20 min"), while the NE group was said they were receiving an inert cream.
Results: Behavioural results showed that pain perception fluctuations mimicked verbal suggestions on cream effectiveness onset. Exploratory analyses of fNIRS signals seem to follow the same pattern: OHb levels varied by group and time course. In the NE group, no significant differences emerged. In the P5 group, frontal areas were engaged when placebo analgesia occurred soon after treatment, while later, both P5 and P20 showed sustained placebo-related activations alongside areas linked to time perception and memory.
Conclusion: This study proposes that the cortical network related to the placebo effect may be active and modulated by temporal information of cream effectiveness, as well as their behavioural respective.
Significance Statement: Implementing fNIRS technology, this study confirms previous behavioral findings and begins to show that cerebral networks respond and encode the temporal characteristics of placebo analgesia. Understanding whether the placebo effect can be switched on and off at specific time points through verbal suggestion could be harnessed when clinically beneficial, aligning its timing with that of pharmacological action, especially for drugs with delayed onset, to ensure continuous pain relief, reduce drug intake, and enhance patient comfort.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314852 | PMC |
http://dx.doi.org/10.1002/ejp.70093 | DOI Listing |
Br J Anaesth
September 2025
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: Despite widespread adoption of ketamine into enhanced recovery after surgery (ERAS) protocols, research regarding its specific impact on perioperative outcomes is limited. This pragmatic, randomised, double-blind, placebo-controlled, single-cluster trial evaluated the impact of ketamine on postoperative outcomes in patients undergoing major abdominal surgery within an established ERAS protocol.
Methods: Male and female patients, aged ≥18 yr, were randomised to ketamine or saline placebo bolus at induction of general anaesthesia, followed by an intraoperative and postoperative infusion for 48 h.
JAMA Surg
September 2025
Department of Surgery, University of California, Irvine, Orange.
Importance: Traumatic rib fractures are associated with significant morbidity, including pulmonary complications and prolonged opioid use. Identifying adjunctive treatments that can reduce opioid consumption without compromising safety remains a clinical priority, particularly in nonintubated trauma patients.
Objective: To evaluate whether adding dexmedetomidine to standard multimodal analgesia reduces opioid consumption in nonintubated patients in the intensive care unit (ICU) with traumatic rib fractures.
Pain Ther
September 2025
Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic.
Introduction: Rebox therapy is a form of noninvasive transcutaneous electrotherapy, which delivers microcurrent kilohertz-frequency pulses in multiple points over the target area. Despite decades of use in pain management, clinical evidence supporting Rebox remains inconclusive, with a lack of rigorous sham-controlled trials. This study aimed to evaluate its analgesic effect in a single-center, randomized, double-blind, sham-controlled crossover trial.
View Article and Find Full Text PDFJ Dent
September 2025
School of Dentistry, The University of Queensland, Brisbane, QLD, Australia. Electronic address:
Objectives: The purpose of this narrative review is to explore the challenges and limitations in the methodologies for evaluating the analgesic effects of photobiomodulation in dentistry.
Study Selection, Data & Sources: The literature published up to April 2025 in the English language was sourced from online databases and reference lists; search engines included Medline, PubMed, Embase, Scopus, and Google Scholar; the relevance of papers was discussed by two reviewers; and a total of 42 publications were included in this narrative review. If there was disagreement between the two reviewers, a third one moderated the selection process.
Clin Spine Surg
September 2025
Department of Neurosurgery, Westchester Medical Center, Valhalla, NY.
Study Design: Systematic review and meta-analysis.
Objective: This study aimed to estimate the safety and efficacy of gabapentinoid usage in ERAS protocols for spine surgery through a systematic review and meta-analysis.
Summary Of Background Data: Enhanced Recovery after Surgery (ERAS) is a perioperative strategy designed to improve surgical outcomes through multimodal protocols.